Sunaga, N
76  Ergebnisse:
Personensuche X
?
1

Efficacy of platinum combination chemotherapy after first-l..:

Masuda, T. ; Imai, H. ; Kuwako, T....
Clinical and Translational Oncology.  17 (2015)  9 - p. 702-709 , 2015
 
?
 
?
4

Clinicopathological and Therapeutic Significance of CXCL12 ..:

Imai, H. ; Sunaga, N. ; Shimizu, Y....
International Journal of Immunopathology and Pharmacology.  23 (2010)  1 - p. 153-164 , 2010
 
?
5

CXCR4+FOXP3+CD25+ Lymphocytes Accumulate in CXCL12-Expressi..:

Shimtzu, Y. ; Dobashi, K. ; Imai, H....
International Journal of Immunopathology and Pharmacology.  22 (2009)  1 - p. 43-51 , 2009
 
?
6

Expectoration of bronchogenic tumour tissue:

Kaira, K. ; Shimizu, Y. ; Sunaga, N....
Internal Medicine Journal.  37 (2007)  5 - p. 340-342 , 2007
 
?
 
?
 
?
 
?
11

Epiregulin as a therapeutic target in non-small-cell lung c..:

Sunaga N ; Kaira K
https://www.dovepress.com/epiregulin-as-a-therapeutic-target-in-non-small-cell-lung-cancer-peer-reviewed-article-LCTT.  , 2015
 
?
 
?
 
?
14

DNA methylation-associated inactivation of TGFβ-related gen..:

Suzuki, M ; Shigematsu, H ; Shames, D S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859959.  , 2013
 
?
15

Prognostic significance of L-type amino-acid transporter 1 ..:

Kaira, K ; Sunose, Y ; Arakawa, K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419959.  , 2012
 
1-15